Alector (ALEC) Total Liabilities (2018 - 2026)
Alector (ALEC) reported Total Liabilities of $229.5 million for Q1 2026, down 26.83% year-over-year from $313.7 million in Q1 2025, and down 12.59% quarter-over-quarter from $262.6 million in Q4 2025.
Alector (ALEC) Total Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Total Liabilities data on file, last reported at $229.5 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $229.5 million, down 26.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $229.5 million (down 26.83% YoY), and the FY2025 annual result was $262.6 million, down 23.11% from the prior year.
- Total Liabilities slipped to $229.5 million in Q1 2026 per ALEC's latest filing, from $262.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $686.9 million in Q1 2022 and troughed at $229.5 million in Q1 2026.
- A 5-year average of $441.4 million and a median of $456.6 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 223.2% in 2022, then sank 32.11% in 2025.
- A 5-year view of Total Liabilities shows it stood at $573.2 million in 2022, then dropped by 14.92% to $487.7 million in 2023, then fell by 29.97% to $341.5 million in 2024, then decreased by 23.11% to $262.6 million in 2025, then dropped by 12.59% to $229.5 million in 2026.
- Business Quant data shows ALEC's Total Liabilities at $229.5 million in Q1 2026, $262.6 million in Q4 2025, and $277.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 229.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.53 Mn |
| Dec 31, 2025 | 262.59 Mn |
| Sep 30, 2025 | 277.57 Mn |
| Jun 30, 2025 | 285.25 Mn |
| Mar 31, 2025 | 313.69 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 397.09 Mn |
| Jun 30, 2024 | 420.16 Mn |
| Mar 31, 2024 | 456.59 Mn |
| Dec 31, 2023 | 487.67 Mn |
| Sep 30, 2023 | 509.84 Mn |
| Jun 30, 2023 | 512.43 Mn |
| Mar 31, 2023 | 565.33 Mn |
| Dec 31, 2022 | 573.21 Mn |
| Sep 30, 2022 | 583.93 Mn |
| Jun 30, 2022 | 601.16 Mn |
| Mar 31, 2022 | 686.92 Mn |
| Dec 31, 2021 | 513.93 Mn |
| Sep 30, 2021 | 518.34 Mn |
| Jun 30, 2021 | 212.60 Mn |